John D. Pak

Array ( [id] => 8055917 [patent_doc_number] => 20120077697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Methods for Selecting Oocytes and Competent Embryos with High Potential for Pregnancy Outcome' [patent_app_type] => utility [patent_app_number] => 13/264589 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9029 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077697.pdf [firstpage_image] =>[orig_patent_app_number] => 13264589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6505740 [patent_doc_number] => 20100260846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND RELATED DEVICES AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/756632 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14534 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260846.pdf [firstpage_image] =>[orig_patent_app_number] => 12756632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227889 [patent_doc_number] => 20120142088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'DNA-CELL CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/263129 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 37687 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953232 [patent_doc_number] => 20110033934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Transcriptome Transfer Produces Cellular Phenotype Conversion' [patent_app_type] => utility [patent_app_number] => 12/755277 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20404 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033934.pdf [firstpage_image] =>[orig_patent_app_number] => 12755277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277419 [patent_doc_number] => 20120171289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'DELIVERY SYSTEMS FOR BIOACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/731093 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23924 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12731093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818634 [patent_doc_number] => 20120065254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'C5A binding nucleic acids and the use thereof' [patent_app_type] => utility [patent_app_number] => 13/259007 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 47393 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065254.pdf [firstpage_image] =>[orig_patent_app_number] => 13259007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9454729 [patent_doc_number] => 08715732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Nucleic acid hydrogel via rolling circle amplification' [patent_app_type] => utility [patent_app_number] => 12/652707 [patent_app_country] => US [patent_app_date] => 2010-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18918 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12652707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484887 [patent_doc_number] => 20110250299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ORGANOGEL COMPOSITIONS AND PROCESSES FOR PRODUCING' [patent_app_type] => utility [patent_app_number] => 13/128530 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6872 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250299.pdf [firstpage_image] =>[orig_patent_app_number] => 13128530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270457 [patent_doc_number] => 08211959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Biodegradable copolymer hydrogels' [patent_app_type] => utility [patent_app_number] => 12/570588 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5182 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12570588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6088085 [patent_doc_number] => 20110217367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'MEANS FOR INHIBITING THE EXPRESSION OF ORC-1' [patent_app_type] => utility [patent_app_number] => 13/120430 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27585 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217367.pdf [firstpage_image] =>[orig_patent_app_number] => 13120430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220074 [patent_doc_number] => 20100055169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'CATIONIC LIPIDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/557230 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50495 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055169.pdf [firstpage_image] =>[orig_patent_app_number] => 12557230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937727 [patent_doc_number] => 20110213020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'IMMUNOSTIMULANT COMPOSITIONS COMPRISING A NUCLEOBASE AND A POLYSACCHARIDE OBTAINABLE FROM FUNGI, YEAST OR BACTERIA' [patent_app_type] => utility [patent_app_number] => 13/121147 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5835 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213020.pdf [firstpage_image] =>[orig_patent_app_number] => 13121147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223309 [patent_doc_number] => 20100056609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITION OF AXONAL DEGENERATION BY MODULATION OF THE DLK/JNK PATHWAY' [patent_app_type] => utility [patent_app_number] => 12/548411 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6033 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056609.pdf [firstpage_image] =>[orig_patent_app_number] => 12548411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220072 [patent_doc_number] => 20100055167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'STEM CELL DELIVERY OF ANTI-NEOPLASTIC MEDICINE' [patent_app_type] => utility [patent_app_number] => 12/546969 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15373 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055167.pdf [firstpage_image] =>[orig_patent_app_number] => 12546969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103915 [patent_doc_number] => 08153605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Modulation of toll-like receptor 3 expression by antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/534911 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10536 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153605.pdf [firstpage_image] =>[orig_patent_app_number] => 12534911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479496 [patent_doc_number] => 20100041734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'MODULATION OF TOLL-LIKE RECEPTOR 7 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/534462 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11320 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041734.pdf [firstpage_image] =>[orig_patent_app_number] => 12534462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189718 [patent_doc_number] => 20120117671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'STEATOHEPATITIS-LIVER CANCER MODEL ANIMAL' [patent_app_type] => utility [patent_app_number] => 13/319851 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6106 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20120117671.pdf [firstpage_image] =>[orig_patent_app_number] => 13319851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549011 [patent_doc_number] => 08323891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'miRNA triplex formations for the downregulation of viral replication' [patent_app_type] => utility [patent_app_number] => 12/512090 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13313 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935876 [patent_doc_number] => 20110212060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'USE OF MICROPARTICLES CONTAINING GENETICALLY MODIFIED CELLS IN THE TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/055554 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212060.pdf [firstpage_image] =>[orig_patent_app_number] => 13055554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103013 [patent_doc_number] => 08153155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery system' [patent_app_type] => utility [patent_app_number] => 12/496568 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 36 [patent_no_of_words] => 10746 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153155.pdf [firstpage_image] =>[orig_patent_app_number] => 12496568 [rel_patent_id] =>[rel_patent_doc_number] =>)